drugset / Trial / NCT04306237
A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Refractory Angina
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objectives of the study are to assess the safety, tolerability, and potential efficacy of IMB-1018972 on patients with refractory angina. Study will assess functional capacity employing a modified Bruce Protocol treadmill ETT, patient reports of angina symptoms via an electronic diary, and activity using an accelerometer.
Timeline
- Start
- 2020-05-01
- Primary completion
- 2025-02
- Completion
- 2025-04
Outcome
Outcome not reported
Stopped: “Coronavirus pandemic”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ninerafaxstat | Small molecule | 200 mg | Oral |